Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Two MORU colleagues and friends have made the Social Media Awards: Malaria Heroes shortlist: Sara Canavati and Cameron Conway.

Sara Canavati with the text: FINALIST - "Sara has dedicated much of her career to promote information on malaria through different social networks. Her Facebook page has inspired many as she keeps her colleagues involved in the latest malaria issues" - Carlos Rivera

An Oxford grad who has worked with SMRU and COMRU, Sara Canavati, is a senior research scientist and infectious diseases epidemiologist who has conducted clinical trials and malaria studies in the Greater Mekong subregion for the last 10 years. She is a finalist in the Regional Malaria Champion Asia Pacific category, and was nominated by the Asia Pacific Malaria Elimination Network (APMEN).

Sara’s primary research interests include malaria elimination, drug efficacy studies; artemisinin and MDR resistance; and the mobile and migrant populations at higher risk of malaria.

An active social media user since 2008 when she did her MSc at the University of Oxford, Sara strongly believes that malaria advocacy is crucial for malaria elimination.

“Scientists can benefit enormously by using social media to promote their own work and stay current in other’s scientists work,” says Sara. “Importantly, social media is a powerful tool to engage non-science audiences in malaria control and elimination. It is a very rewarding activity that all scientists should get more involved in.

Cameron Conway, a former Wellcome Trust-funded Poet in Residence at MORU, was nominated in the People’s Choice for Best Communications category. Cameron is the author of Malaria Poems, which was a 2015 Pulitzer Prize Poetry nominee.

Similar stories

Laos’ first Pint of Science: warty newts, COVID, AI for Instagram, and more!

Organised by a grass-root community of thousands of scientists across the world, Pint of Science 2022 allowed researchers in 25 countries and over 800 cities to share their latest findings with lay folk in interesting, informal settings. Lao PDR joined the global Pint of Science family on Monday 9 May, when the first-ever Pint of Science Laos kicked off!

Patient recruitment on track in Oxford-led DeTACT trial of safe, effective drug combinations to prevent the spread of artemisinin and multi-drug resistant malaria in Africa

Today is World Malaria Day. The global fight against malaria is at a critical point. No new antimalarial drugs are expected in the near future, and if multi-drug resistant falciparum malaria becomes established in East Africa and spreads to other parts of Africa, millions will be at risk of drug-resistant malaria infection and death. The development of triple artemisinin-based combination therapies aims to prevent or delay the emergence of artemisinin and multi-drug resistant malaria in Africa.

PRIORITISE study team publishes results, now seeks partners

In regions where few people have received Covid-19 vaccines, health systems remain vulnerable to surges in SARS-CoV-2 infections. During the delta-wave of COVID-19 in India, for example, healthcare facilities and staff across the country struggled to cope with the surge in the number of cases of COVID-19 due to a shortage of hospital beds for people with severe cases, plus shortages of medicines and limited human resources.

Under the Mask, drama film based on testimonies of tuberculosis patients

In 2022, tuberculosis (TB) remains a major global health problem, particularly in developing countries. On the Thai-Myanmar border, TB is an important problem among migrants, a vulnerable, very mobile population, with unstable, often difficult living conditions, insecure incomes, and poor access to health services.

TACT-CV study shows artemether–lumefantrine plus amodiaquine an effective treatment for multidrug-resistant malaria in GMS

A triple artemisinin-based combination therapy (TACT) of artemether-lumefantrine plus amodiaquine (AL+AQ) for uncomplicated falciparum malaria in areas with a high prevalence of artemisinin resistance is a well-tolerated, effective treatment for multidrug-resistant parasites, say a team of MORU-led researchers.

Study finds steady increase in WHO-validated artemisinin resistance markers in Asia

From 2002-2018, there has been a steady increase in the places and proportion of infected people reporting validated kelch13 (K13) artemisinin resistance markers, according to a study in The Lancet Microbe. This increase in artemisinin resistance threatens efforts to eliminate malaria in Asia by 2030 — and control efforts in other endemic regions. The authors say that more consistent data collection, over longer time periods in the same areas, and rapid sharing of data are needed to map the spread of resistance and better inform policy decisions.